AHAdil El Housseini

Adil El Housseini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adil El Housseini has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biomaterials derived from bioresources as therapeutic tools against scorpion envenomation

    by Adil El Housseini, Youssef Ait Hamdan, Sara El Aimani, Assia Sabbar, Moulay Abdelmonaim El Hidan, El-Mustapha Laghzaoui, El Hassan El Mouden, Mustapha Agnaou

  • Open Access

    Extraction, characterization, and pharmacological investigations of chitosan from the scorpion Scorpio mogadorensis (Birula, 1910)

    by Youssef Ait Hamdan, Adil El Housseini, Nadia Eladlani, Moulay Abdelmonaim El Hidan, Abdelaati El Khiat, Mohammed Rhazi

  • Scorpion Venom and Biodegradable Biomaterials

    by Adil El Housseini, Khawla Rachmoune, Sara El Aimani, Youssef El Joud, Moulay Abdelmonaim El Hidan, El-Mustapha Laghzaoui, Mehdi Ait Laaradia, El Hassan El Mouden, Mustapha Agnaou

    Scorpion venom is known for its richness in bioactive molecules, particularly peptides, which confer a wide range of remarkable biological activities. Notably, it exhibits antimicrobial, antitumor, and immunomodulatory effects. However, its clinical translation remains limited due to its poor stability, dose-dependent toxicity, and potential immunogenicity. In this context, biodegradable biomaterials have emerged as promising platforms to overcome these limitations. They enable precise, targeted, and sustained delivery of scorpion venom peptides. This chapter highlights an innovative approach based on the integration of scorpion venom into biodegradable biopolymer matrices for applications in modern medicine. By leveraging the unique properties of biodegradable biomaterials, this work outlines a roadmap for the development of next-generation clinical applications.

  • Kinetics of brain oxidative stress in mice after envenomation by Hottentotta gentili (Pallary, 1924)

    by Adil EL Housseini, Abdelmohcine Aimrane, Youssef EL Joud, Mehdi Ait Laaradia, El-Mustapha Laghzaoui, EL Hassan EL Mouden, Moulay Abdelmonaim EL Hidan, Mohammed Rhazi, Jaouad Abou Oualid, Et Mustapha Agnaou


  • Secondary Metabolites

    by Adil El Housseini, Khawla Rachmoune, Abdelfatah Ait Baba, Youssef Ait Hamdan, Imade Armadi, Chaymaa Harkat, El-Mustapha Laghzaoui, Kholoud Kahime, Moulay Abdelmonaim El Hidan, Mehdi Ait Larradia, et al.

    Alzheimer's, Parkinson's, and various neurodegenerative diseases are generally characterized by neuronal loss, which directly induces cognitive and motor dysfunctions. Secondary metabolites, as natural products of aromatic and medicinal plants and other origins, could present a promising alternative source to combat neurodegenerative diseases. With their important phytochemical composition, especially in alkaloids, terpenes, flavonoids, and polyphenols, these secondary metabolites pave the way for the development of new therapies. Their neuroprotective properties and their antioxidant and anti-inflammatory activities constitute a solid basis for their use in the fight against neurodegenerative diseases. This chapter aims to explore the therapeutic effects of secondary metabolites in the fight against neurodegenerative diseases while discussing the responsible mechanisms, challenges, perspectives, as well as the limits of this application.


  • Therapeutic Implications of Chitosan and Its Derivatives

    by Youssef Ait Hamdan, Imade Armadi, Khawla Rachmoune, Fatima Ezzahra Elamrani, Maryem Mekouar, Adil El Housseini, Aicha Moufakkir, Samia Elouali, Souad Loqman, Anass Belbachir, et al.

    Chitosan and its derivatives have garnered increasing interest in oncology due to their unique properties, such as biocompatibility, bioactivity and their ability to interact with molecules. These characteristics make them promising candidates for the development of novel anticancer therapies. Chitosan can be employed as drug delivery systems, enhancing the availability and targeted release of therapeutic agents into cancer cells. Additionally, they have demonstrated the ability to inhibit cell proliferation, induce apoptosis, and modulate immune responses, positioning them as multifunctional tools in the fight against cancer. Recent research has focused on the development of chitosan-based nanoparticles for targeted drug delivery in chemotherapy, reducing side effects on healthy cells. Furthermore, Chitosan systems have been used to deliver siRNA and other therapeutic molecules, inhibiting tumor growth at the genetic level. These advancements highlight chitosan's potential in developing more effective and less toxic cancer treatments.

  • Chitosan Polysaccharides for Osteoporosis Therapy in Postmenopausal Women

    by Youssef Ait Hamdan, Imade Armadi, Saloua Mabsor-Zgandaoui, Fatima Ezzahra Elamrani, Khawla Rachmoune, Adil El Housseini, Meriem Mekouar, Amina El Kaoui, Maysae Chehber, Priscilla Barbosa Sales de Albuquerque, et al.

    Osteoporosis is a common degenerative disease in postmenopausal women, characterized by a loss of bone density and skeletal fragility, increasing fracture risk. This chapter examines the use of chitosan, a natural biopolymer derived from chitin, as a therapeutic agent in osteoporosis treatment. Chitosan's unique properties, such as biocompatibility, biodegradability, and the ability to form three-dimensional structures, make it a promising candidate for bone therapies. The chapter also analyzes chemical and functional modifications to chitosan that enhance its bioactive effects and drug delivery capabilities, offering promising perspectives for non-hormonal osteoporosis treatments.

  • Biomedical Polymers

    by Saloua Mabsor-Zgandaoui, Khawla Rachmoune, Ilham Aftais, Fatima Ezzahra Elamrani, Imade Amradi, Adil El Housseini, Youssef Ait Hamdan, Youness Zgandaoui, Abdelghani Iddar, Mohammed El Mzibri, et al.

    Biomedical polymers have played a transformative role in modern medicine, driving innovation in drug delivery, tissue engineering and medical devices. These materials are classified as natural or synthetic and possess unique properties such as biocompatibility, biodegradability and mechanical versatility. Natural polymers support cellular functions and tissue regeneration, while synthetic polymers allow precise control of degradation rates and mechanical properties. Polymers have facilitated the controlled delivery of drugs through polymer-drug conjugates and stimulant systems, enabling targeted and sustained release. However, challenges such as toxicity, immune responses and regulatory hurdles remain. By exploring their applications, challenges and future prospects, this chapter has shed light on the essential role of biomedical polymers in advancing personalized medicine, regenerative therapies and smart medical devices.


  • Radioprotective Effects of Chitosan Polysaccharides and Biomedical Applications

    by Khawla Rachmoune, Saloua Mabsor-Zgandaoui, Adil El Housseini, Youssef Ait Hamdan, Maryam Bousaid, Adil Aknouch, Mohammed Rhazi, Adem Gharsallaoui, Abdelghani Iddar, Mohammed El Mzibri, et al.

    Ionizing radiation (IR) plays a central role in the biomedical field, both for diagnosis and for the treatment of pathologies such as cancer. However, exposure to IR can cause significant cellular damage, affecting both tumor cells and neighbouring healthy tissue. In this context, the use of effective radioprotective agents is a necessity. Chitosan (CS), a natural biopolymer derived from chitin, stands out for its antioxidant, anti-inflammatory and reparative properties, as well as its biocompatibility and biodegradability. These characteristics make it a promising candidate for radiation protection. This chapter examines the radioprotective mechanisms of chitosan, in particular its ability to trap reactive oxygen species and enhance the activity of antioxidant enzymes. It also highlights its many biomedical applications, particularly in tissue engineering and controlled drug release. Finally, the limits to its clinical use and recent advances aimed at improving its physico-chemical properties are discussed, paving the way for new therapeutic strategies in radiation protection.


  • Overview of Biomaterials Classification, Properties, and Biomedical Applications

    by Imade Armadi, Samia Elouali, Abdessamad Abana, Adil El Housseini, Souad Loqman, Anass Belbachir

    Biomaterials have attracted growing interest in the biomedical field thanks to their unique ability to interact with biological systems and make a significant contribution to advances in medicine, tissue engineering and sustainable technologies. Their importance lies in their dual potential: improving patients' quality of life while reducing their impact on the environment. This chapter first presents a detailed classification of biomaterials, distinguishing between natural, synthetic and hybrid categories. Next, the key properties of biomaterials are explored, showing their role in biocompatibility, durability and clinical performance. These fundamental characteristics directly influence the choice of biomaterials for a variety of applications. In addition, this chapter highlights the diversity of current biomaterial applications, while discussing the persistent challenges and limitations encountered in their design and use. Finally, future prospects are discussed, including the emergence of personalized biomaterials, which could revolutionize biomedical technologies.